Carlos Rodriguez
@carodriguez-1.bsky.social
Escuchar, comunicar, resolver. Seasoned for 6 years in the UK. Da un po’ facendo strada dove il cuore mi porta.
Reposted by Carlos Rodriguez
🌍 Radiotherapy is a key component of multidisciplinary GU cancer care.
This #WorldRTDay, join the conversation at #ESMOGUAsia27.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/URfk50ZJg3a
#WRAD #ESMOMeetings
This #WorldRTDay, join the conversation at #ESMOGUAsia27.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/URfk50ZJg3a
#WRAD #ESMOMeetings
September 7, 2026 at 5:00 AM
🌍 Radiotherapy is a key component of multidisciplinary GU cancer care.
This #WorldRTDay, join the conversation at #ESMOGUAsia27.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/URfk50ZJg3a
#WRAD #ESMOMeetings
This #WorldRTDay, join the conversation at #ESMOGUAsia27.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/URfk50ZJg3a
#WRAD #ESMOMeetings
Reposted by Carlos Rodriguez
🚀 NEW: ESMO Genitourinary Cancers Asia 2027
📢 Abstract submission is now open
📅 Deadline: 13 October
🎥 Watch the launch video & be part of the future of GU oncology.
👉 https://ow.ly/uoNo50Zk30N
#ESMOMeetings #ESMOGUAsia27
📢 Abstract submission is now open
📅 Deadline: 13 October
🎥 Watch the launch video & be part of the future of GU oncology.
👉 https://ow.ly/uoNo50Zk30N
#ESMOMeetings #ESMOGUAsia27
July 10, 2026 at 7:01 AM
🚀 NEW: ESMO Genitourinary Cancers Asia 2027
📢 Abstract submission is now open
📅 Deadline: 13 October
🎥 Watch the launch video & be part of the future of GU oncology.
👉 https://ow.ly/uoNo50Zk30N
#ESMOMeetings #ESMOGUAsia27
📢 Abstract submission is now open
📅 Deadline: 13 October
🎥 Watch the launch video & be part of the future of GU oncology.
👉 https://ow.ly/uoNo50Zk30N
#ESMOMeetings #ESMOGUAsia27
Reposted by Carlos Rodriguez
⏳ Still time to join #ESMOTATAsia26
Be part of ESMO Targeted Anticancer Therapies Asia 2026, a key Asia Pacific forum for cancer drug development.
👉 Register by 3 June and save: https://ow.ly/WKAw50Z4GEK
#ESMOMeetings
Be part of ESMO Targeted Anticancer Therapies Asia 2026, a key Asia Pacific forum for cancer drug development.
👉 Register by 3 June and save: https://ow.ly/WKAw50Z4GEK
#ESMOMeetings
May 28, 2026 at 8:02 AM
⏳ Still time to join #ESMOTATAsia26
Be part of ESMO Targeted Anticancer Therapies Asia 2026, a key Asia Pacific forum for cancer drug development.
👉 Register by 3 June and save: https://ow.ly/WKAw50Z4GEK
#ESMOMeetings
Be part of ESMO Targeted Anticancer Therapies Asia 2026, a key Asia Pacific forum for cancer drug development.
👉 Register by 3 June and save: https://ow.ly/WKAw50Z4GEK
#ESMOMeetings
Reposted by Carlos Rodriguez
⏰ Early registration for #ESMOTAT26 ends 28 Jan!
Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
January 14, 2026 at 3:01 PM
⏰ Early registration for #ESMOTAT26 ends 28 Jan!
Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
Join a leading multi-stakeholder forum on cancer #drugdiscovery in Paris.
🔗 Register now: https://ow.ly/VQce50XWy9H
#ESMOMeetings #targetedtherapies #PrecisionMedicine #ClinicalTrials
Reposted by Carlos Rodriguez
🙌Today, we witnessed the power of togetherness at #ESMOAsia25. Crowded rooms, meaningful discussions, and groundbreaking research, all united by one mission: improving patient outcomes in Asia. #esmomeetings
👉 Together, we shape the future of oncology: buff.ly/qHVAi4F
👉 Together, we shape the future of oncology: buff.ly/qHVAi4F
December 5, 2025 at 10:01 AM
🙌Today, we witnessed the power of togetherness at #ESMOAsia25. Crowded rooms, meaningful discussions, and groundbreaking research, all united by one mission: improving patient outcomes in Asia. #esmomeetings
👉 Together, we shape the future of oncology: buff.ly/qHVAi4F
👉 Together, we shape the future of oncology: buff.ly/qHVAi4F
Reposted by Carlos Rodriguez
📣 Registration for #ESMOTATAsia26 is open! Join global experts in #precisiononcology and discover the latest breakthroughs in cancer #drugdevelopment
🔗 https://ow.ly/oQRg50XBOZZ
⏰ Early Registration applies until 8 April 2026.
🔗 https://ow.ly/oQRg50XBOZZ
⏰ Early Registration applies until 8 April 2026.
December 4, 2025 at 11:00 PM
📣 Registration for #ESMOTATAsia26 is open! Join global experts in #precisiononcology and discover the latest breakthroughs in cancer #drugdevelopment
🔗 https://ow.ly/oQRg50XBOZZ
⏰ Early Registration applies until 8 April 2026.
🔗 https://ow.ly/oQRg50XBOZZ
⏰ Early Registration applies until 8 April 2026.
Reposted by Carlos Rodriguez
Are you ready for radioligand therapy? Join the next #ESMOOnAir webinar part of the Therapeutic Landscapes series:
- Science, clinical trials & system readiness for RLT
- Live expert Q&A
🔗 https://ow.ly/fsmX50XnByi
#Oncology #Radiotheranostics #CancerCare #RLT #MedicalEducation
- Science, clinical trials & system readiness for RLT
- Live expert Q&A
🔗 https://ow.ly/fsmX50XnByi
#Oncology #Radiotheranostics #CancerCare #RLT #MedicalEducation
November 7, 2025 at 10:00 AM
Are you ready for radioligand therapy? Join the next #ESMOOnAir webinar part of the Therapeutic Landscapes series:
- Science, clinical trials & system readiness for RLT
- Live expert Q&A
🔗 https://ow.ly/fsmX50XnByi
#Oncology #Radiotheranostics #CancerCare #RLT #MedicalEducation
- Science, clinical trials & system readiness for RLT
- Live expert Q&A
🔗 https://ow.ly/fsmX50XnByi
#Oncology #Radiotheranostics #CancerCare #RLT #MedicalEducation
Reposted by Carlos Rodriguez
👉 Don’t miss the key takeaways from #ESMO25! Join us for the last ESMO Congress Highlights Webinar on Thoracic, Head & Neck, and Melanoma Cancers
Free registration with your ESMO account: #oncology #cancerresearch #ESMOwebinars
🔗 https://ow.ly/Sw2N50XiVaF
Free registration with your ESMO account: #oncology #cancerresearch #ESMOwebinars
🔗 https://ow.ly/Sw2N50XiVaF
October 30, 2025 at 10:55 AM
👉 Don’t miss the key takeaways from #ESMO25! Join us for the last ESMO Congress Highlights Webinar on Thoracic, Head & Neck, and Melanoma Cancers
Free registration with your ESMO account: #oncology #cancerresearch #ESMOwebinars
🔗 https://ow.ly/Sw2N50XiVaF
Free registration with your ESMO account: #oncology #cancerresearch #ESMOwebinars
🔗 https://ow.ly/Sw2N50XiVaF
Reposted by Carlos Rodriguez
Registration is open for the #ESMO25 Congress Highlights Webinar on #GastrointestinalCancers!
🎓 Expert insights, clinical relevance, live Q&A
✅ Free for all ESMO account holders #ESMOWebinars
🔗 https://ow.ly/iWJb50XiRKf
🎓 Expert insights, clinical relevance, live Q&A
✅ Free for all ESMO account holders #ESMOWebinars
🔗 https://ow.ly/iWJb50XiRKf
October 28, 2025 at 11:01 AM
Registration is open for the #ESMO25 Congress Highlights Webinar on #GastrointestinalCancers!
🎓 Expert insights, clinical relevance, live Q&A
✅ Free for all ESMO account holders #ESMOWebinars
🔗 https://ow.ly/iWJb50XiRKf
🎓 Expert insights, clinical relevance, live Q&A
✅ Free for all ESMO account holders #ESMOWebinars
🔗 https://ow.ly/iWJb50XiRKf
Reposted by Carlos Rodriguez
The breakthroughs from #ESMO25, at your fingertips! 🎓 Expert-led, free, and open to all ESMO account holders. 📲 Register now and let ESMO bring the Congress experience to you:
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
October 27, 2025 at 9:40 AM
The breakthroughs from #ESMO25, at your fingertips! 🎓 Expert-led, free, and open to all ESMO account holders. 📲 Register now and let ESMO bring the Congress experience to you:
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
Reposted by Carlos Rodriguez
📣 Abstract submission is open for #ESMOTAT26
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
September 19, 2025 at 7:00 AM
📣 Abstract submission is open for #ESMOTAT26
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
Showcase your research in #Cancer #DrugDiscovery & #TargetedTherapies.
Deadline: 16 December
🔗 Submit now: buff.ly/a4kXwWN
Reposted by Carlos Rodriguez
📖 The ESMO Targeted Anticancer Therapies Asia Congress 2025 resources are now available on OncologyPro. 🔗 buff.ly/OSLsJ2x
📚 Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.
📚 Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.
July 21, 2025 at 2:30 PM
📖 The ESMO Targeted Anticancer Therapies Asia Congress 2025 resources are now available on OncologyPro. 🔗 buff.ly/OSLsJ2x
📚 Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.
📚 Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.
Reposted by Carlos Rodriguez
📢 ESMO is now on WeChat!
Follow myESMO for news, resources & updates — supporting our commitment to global oncology.
📲 Search for myESMO on WeChat to follow us.
Follow myESMO for news, resources & updates — supporting our commitment to global oncology.
📲 Search for myESMO on WeChat to follow us.
July 8, 2025 at 5:00 AM
📢 ESMO is now on WeChat!
Follow myESMO for news, resources & updates — supporting our commitment to global oncology.
📲 Search for myESMO on WeChat to follow us.
Follow myESMO for news, resources & updates — supporting our commitment to global oncology.
📲 Search for myESMO on WeChat to follow us.
Reposted by Carlos Rodriguez
📣 Join us in Hong Kong for a chance to contribute to oncology drug development in Asia Pacific!
⏰ Late registration deadline: 18 June
🔗 buff.ly/UslUr2V
⏰ Late registration deadline: 18 June
🔗 buff.ly/UslUr2V
June 14, 2025 at 7:01 AM
📣 Join us in Hong Kong for a chance to contribute to oncology drug development in Asia Pacific!
⏰ Late registration deadline: 18 June
🔗 buff.ly/UslUr2V
⏰ Late registration deadline: 18 June
🔗 buff.ly/UslUr2V
Reposted by Carlos Rodriguez
👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes.
Join this live discussion and submit your questions
🔗 buff.ly/nj2nMtC
Join this live discussion and submit your questions
🔗 buff.ly/nj2nMtC
May 23, 2025 at 1:27 PM
👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes.
Join this live discussion and submit your questions
🔗 buff.ly/nj2nMtC
Join this live discussion and submit your questions
🔗 buff.ly/nj2nMtC
Reposted by Carlos Rodriguez
🔬Latest studies on #gastroenteropancreatic (NETTER-2) and #cervical (KEYNOTE-826) cancers will be critically reviewed by experts in the field. Register with your membership for this new #ESMOVirtualJournalClub and join the live Q&A discussion!
🔗 buff.ly/tXjyalk
🔗 buff.ly/tXjyalk
May 20, 2025 at 8:20 PM
🔬Latest studies on #gastroenteropancreatic (NETTER-2) and #cervical (KEYNOTE-826) cancers will be critically reviewed by experts in the field. Register with your membership for this new #ESMOVirtualJournalClub and join the live Q&A discussion!
🔗 buff.ly/tXjyalk
🔗 buff.ly/tXjyalk
Reposted by Carlos Rodriguez
This is an observational study, so it can't prove causation, but there is experimental data in mice that supports causation.
Collectively, this does seem to be a cause and effect relationsihp.
www.sciencedirect.com/science/arti...
Collectively, this does seem to be a cause and effect relationsihp.
www.sciencedirect.com/science/arti...
Coffee treatment prevents the progression of sarcopenia in aged mice in vivo and in vitro
Sarcopenia is characterized by the age-related loss of muscle mass and strength, which results in higher mortality in aged people. One of the mechanis…
www.sciencedirect.com
May 13, 2025 at 2:44 PM
This is an observational study, so it can't prove causation, but there is experimental data in mice that supports causation.
Collectively, this does seem to be a cause and effect relationsihp.
www.sciencedirect.com/science/arti...
Collectively, this does seem to be a cause and effect relationsihp.
www.sciencedirect.com/science/arti...
Reposted by Carlos Rodriguez
☕ Good news, #coffee people.
You might be protecting yourself from frailty later in life.
A new study found a striking dose–response: the more coffee older adults drank, the lower their odds of frailty.
Drink up!
🧪☕💊
#Longevity #Healthspan
link.springer.com/article/10.1...
You might be protecting yourself from frailty later in life.
A new study found a striking dose–response: the more coffee older adults drank, the lower their odds of frailty.
Drink up!
🧪☕💊
#Longevity #Healthspan
link.springer.com/article/10.1...
May 13, 2025 at 2:36 PM
☕ Good news, #coffee people.
You might be protecting yourself from frailty later in life.
A new study found a striking dose–response: the more coffee older adults drank, the lower their odds of frailty.
Drink up!
🧪☕💊
#Longevity #Healthspan
link.springer.com/article/10.1...
You might be protecting yourself from frailty later in life.
A new study found a striking dose–response: the more coffee older adults drank, the lower their odds of frailty.
Drink up!
🧪☕💊
#Longevity #Healthspan
link.springer.com/article/10.1...
Reposted by Carlos Rodriguez
Come join us in #hongkong 🇭🇰 🍜🥟🥡 for the #inaugural @myesmo.bsky.social #ESMOTATAsia25 on July 18-20, 2025! We have assembled a #stellar group of #international #faculties and #experts in #drugdevelopment to help move the field forward. Register today!
May 7, 2025 at 12:25 PM
Come join us in #hongkong 🇭🇰 🍜🥟🥡 for the #inaugural @myesmo.bsky.social #ESMOTATAsia25 on July 18-20, 2025! We have assembled a #stellar group of #international #faculties and #experts in #drugdevelopment to help move the field forward. Register today!
Reposted by Carlos Rodriguez
📣Final call for early registration! The #ESMOTATAsia25 early registration fees are ending soon.
⏰Register by 14 May and be part of the future of cancer #drugdevelopment.
🔗 buff.ly/e1yAPUD
⏰Register by 14 May and be part of the future of cancer #drugdevelopment.
🔗 buff.ly/e1yAPUD
May 7, 2025 at 3:00 AM
📣Final call for early registration! The #ESMOTATAsia25 early registration fees are ending soon.
⏰Register by 14 May and be part of the future of cancer #drugdevelopment.
🔗 buff.ly/e1yAPUD
⏰Register by 14 May and be part of the future of cancer #drugdevelopment.
🔗 buff.ly/e1yAPUD
Reposted by Carlos Rodriguez
⏰ Less than 1 week left to submit your abstract to #ESMOTATAsia25. Let's accelerate the development of #earlyphasetrials in the region together.
👉 Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nlzr3GY
👉 Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nlzr3GY
April 23, 2025 at 9:32 AM
⏰ Less than 1 week left to submit your abstract to #ESMOTATAsia25. Let's accelerate the development of #earlyphasetrials in the region together.
👉 Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nlzr3GY
👉 Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nlzr3GY
Reposted by Carlos Rodriguez
⏰Less than 2 weeks left to submit your abstract to #ESMOTATAsia25! A fantastic opportunity to showcase your transformative work within the region in a truly international platform.
👉Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nOD4Kzs
👉Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nOD4Kzs
April 16, 2025 at 6:15 AM
⏰Less than 2 weeks left to submit your abstract to #ESMOTATAsia25! A fantastic opportunity to showcase your transformative work within the region in a truly international platform.
👉Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nOD4Kzs
👉Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nOD4Kzs
Reposted by Carlos Rodriguez
Candela Peña denuncia las condiciones de su última oferta laboral: “Una falta de respeto, algo ofensivo e hiriente”
Candela Peña denuncia las condiciones de su última oferta laboral: "Una falta de respeto, algo ofensivo e hiriente"
La actriz Candela Peña ha compartido con sus seguidores la sorprendente situación en la que se ha visto envuelta mientras le hacían una oferta de trabajo
www.eldiario.es
April 11, 2025 at 5:46 PM
Candela Peña denuncia las condiciones de su última oferta laboral: “Una falta de respeto, algo ofensivo e hiriente”
Reposted by Carlos Rodriguez
👉 Share your findings with regional and international experts in #cancer #drugdevelopment.
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 buff.ly/IdnoYdO
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 buff.ly/IdnoYdO
April 4, 2025 at 2:03 PM
👉 Share your findings with regional and international experts in #cancer #drugdevelopment.
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 buff.ly/IdnoYdO
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 buff.ly/IdnoYdO
Reposted by Carlos Rodriguez
Esto es escandaloso.
Son actitudes claramente mafiosas, para beneficiar a las universidades privadas de sus amigos.
Pero la señora presidenta sabe que no le pasarán factura porque tiene las mangas llenas de jueces y la televisión de presentadores falderos.
elpais.com/educacion/20...
Ayuso renuncia a 169 millones del Estado para sus universidades y Morant reacciona: “Pierden la posibilidad de incorporar a 1.000 profesores”
La ministra de Ciencia envía una carta a la presidenta de Madrid en la que sostiene que “perjudica seriamente” a los campus públicos
elpais.com
December 2, 2024 at 2:18 PM
Esto es escandaloso.
Son actitudes claramente mafiosas, para beneficiar a las universidades privadas de sus amigos.
Pero la señora presidenta sabe que no le pasarán factura porque tiene las mangas llenas de jueces y la televisión de presentadores falderos.
elpais.com/educacion/20...